 |
CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ |
| Journals - Contents | |
 |
 |
|
Vnitřní lékařství |
||
|
Gregor P.:
Heart Amyloidosis. A Commentary to a Casuistic by Authors Brychta at all: Restrictive Cardiomyopathy as a Symptom of Primary Amyloidosis. |
6 |
|
Bytešník J.:
Are We Prepared for ”Are We Prepared for the Expected Increase in Number of Cardioverter Defibrillator Implantions”? |
7 |
|
Chrobák L.:
Chronic Myeloid Leukemia and Therapy with Imatinib Mesylate. |
10 |
|
Žaloudík J.:
Prognostics as a logistics of medical balancing. |
12 |
|
Musil D.1, Herman J.2:
Chronic Venous Insufficiency - Out Patient Monitoring of Risk Factors |
14 |
|
Husa P.1, Smejkal P.2, Husová L.3, Chalupa P.1, Penka M.2:
Efficacy in Treatment of Chronic Hepatitis C Patients with Haemophilia Based on Historical Evolution of Recommended Treatment |
30 |
|
Staško J., Hudeček J., Kubisz P.:
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) and its Role in Regulation of Fibrinolysis |
36 |
|
Prausová D.1, Krejsek J.1, Žák P.2, Voglová J.2, Belada D.2:
The Importance of Immunophenotyping in Diagnosis of B-lymhoproliferative Disorders |
45 |
|
Křivan L., Sepši M., Semrád B.:
Caring of Patients with Implantable Cardioverter Defibrillators: What Should the Physicians Know |
54 |
|
Gorbunov E. A., Wechsler J.:
Prognosis and Prognostic Factors in Oncology and Oncosurgery |
61 |
|
Brychta T.1, Pařenica J.1, Zatočil T.1, Maňoušek J.1, Tesák M.1, Schildberger J.1, Kala P.1, Semrád B.1, Brázdil J.2, Číhalová M.2:
Restrictive Cardiomyopathy as a Symptom of Primary Amyloidosis |
66 |
|
Doležal J.1, Horáček J.3, Ceeová V.2, Vižďa J.1:
Mismatch of Scintigraphies with 99mTc-MIBI and 99mTc-pertechnetate in a Patient with Hyperparathyroidism |
72 |
Order this issue |
| | HOME PAGE | CODE PAGE | CZECH VERSION | |
| © 1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ |
| Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o. |
| WEBMASTER |